You are here: Home » Reuters » News
Business Standard

Indivior says 2018 revenue, net income to come in below expectations


(Reuters) - said on Wednesday its 2018 revenue and adjusted net income would come in below its forecast, hurt by the launch of generic versions of its bestselling treatment in the

India's and U.S.-based received approval from the (FDA) last month to launch a generic version of Suboxone Film, which generates 80 percent of Indivior's revenue.

The company previously forecast 2018 net revenue in the range of $1.13 billion to $1.17 billion and adjusted net income of $280 million to $320 million.

(Reporting by in Bengaluru; Editing by Amrutha Gayathri)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, July 11 2018. 11:52 IST